4//SEC Filing
Ros Matthew 4
Accession 0000899243-22-021645
CIK 0001622229other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:09 PM ET
Size
5.7 KB
Accession
0000899243-22-021645
Insider Transaction Report
Form 4
Ros Matthew
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-07+30,700→ 30,700 totalExercise: $4.59Exp: 2032-06-07→ Common Stock (30,700 underlying)
Footnotes (1)
- [F1]This annual stock option award was made on the date of the 2022 Annual Meeting of Stockholders pursuant to the company's Non-Employee Director Compensation Program and shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2023 Annual Meeting of Stockholders.
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001673802
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 5:09 PM ET
- Size
- 5.7 KB